Roger New

Dr. New (BA, PhD) has 34 years‟ experience in research and development in the field of drug delivery and is a world-recognised expert in liposomes and author of seminal reference book “Liposomes - A Practical Approach” published by OUP. He was the first to demonstrate efficacy of liposomal amphotericin and coordinated the first Phase I/II trials of liposomal doxorubicin. During his career he devised three new systems for oral delivery of insulin, giving first positive human results ever observed in Type I diabetics.

Positions - Previous

PositionCompanyYearCompany's current rankWA staff
Bone Medical
Bone Medical
2011 - 2014166
Non-Executive Director
Bone Medical
Bone Medical
2007 - 2014166

Directors Interests

CompanyDateTransaction typeNumber of sharesPrice per shareTransaction valueNature of change
Bone Medical31 Jan 2014Bought13,437,479$0.01$134,375OtherIssue of shares under debt conversion agreement
Bone Medical03 Jul 2012Bought480,062$0.01$6,375OtherShares issued in lieu of cash for services rendered
Bone Medical08 Jul 2011Bought347,916$0.10$34,792OtherShares issued in lieu of cash for services rendered
Source: Morningstar

Share Transactions

$134k Bought
$6k Bought
$35k Bought
Total value as at the date of the transaction
Source: Morningstar

BNiQ Disclaimer